Description
Macdronic 4mg is an intravenous bisphosphonate medication containing Zoledronic Acid. It is used in oncology to treat tumor-induced hypercalcemia and to prevent skeletal complications (such as fractures or spinal compression) in patients with multiple myeloma and advanced cancers that have spread to the bone. [1, 2]
Key Features and Usage
- Administration: It is typically diluted (e.g., in 100 ml of saline or dextrose) and administered slowly as an IV infusion over at least 15 minutes by a healthcare professional. [1]
- Dosage Frequency: For bone metastases, it is typically given every 3 to 4 weeks. For hypercalcemia of malignancy, a single 4mg dose is used, which may be repeated after 7 days if necessary. [1]
- Side Effects: Common reactions include flu-like symptoms (fever, fatigue, bone/muscle pain), nausea, and a decrease in blood phosphate levels
Reviews
There are no reviews yet.